Skip to main content
  • Centogene AG
  • Investment: 2017
  • Status: Active

CENTOGENE is a worldwide leader in the field of genetic diagnostics for rare hereditary diseases – with the largest test portfolio worldwide. Testing samples from over 105 different countries allows CENTOGENE a unique insight into the epidemiological basis of hereditary disorders, which is crucial for interpreting results and transform it into medical reports.

We are dedicated to transforming the science of genetic information into solutions and hope for patients and their families.

Involved Team

Dr. Hubert Birner
Managing Partner,

Kim Stratton (CEO)